Melissa Galloway
Nurse Practitioner · Georgetown, DENPI 1245018878
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 125 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 12.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $1,967 and has fallen 75.1% since, to $489 in 2025. Among nurse practitioner clinicians in DE with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 125 payments — averaging $21.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$333
- AbbVie$296
- Exact Sciences$206
- Lilly USA, LLC$179
- Bayer$173
- Ardelyx, Inc.$162
- plus $1K from 21 others
What the payments were for
- Food & beverage$2,718100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 16 | $333 |
| AbbVie | 16 | $296 |
| Exact Sciences | 8 | $206 |
| Lilly USA, LLC | 8 | $179 |
| Bayer | 10 | $173 |
| Ardelyx, Inc. | 2 | $162 |
| GSK | 8 | $151 |
| Corcept Therapeutics | 4 | $119 |
| Novo Nordisk | 6 | $113 |
| Pfizer | 6 | $112 |
| Sumitomo Pharma America, Inc. | 5 | $104 |
| Esperion Therapeutics, Inc. | 5 | $91 |
| Dexcom, Inc. | 4 | $74 |
| Johnson & Johnson | 3 | $73 |
| Otsuka America Pharmaceutical, Inc. | 3 | $69 |
| Boehringer Ingelheim | 3 | $62 |
| Shield Therapeutics Inc | 1 | $58 |
| Merck | 2 | $57 |
| Phathom Pharmaceuticals, Inc. | 3 | $51 |
| Lundbeck LLC | 2 | $44 |
| Amgen | 2 | $38 |
| Idorsia Pharmaceuticals US Inc | 2 | $38 |
| Novartis | 2 | $37 |
| Eisai Inc. | 1 | $25 |
| Kowa Pharmaceuticals America, Inc. | 1 | $18 |
| Tactile Systems Technology Inc | 1 | $18 |
| Vertos Medical, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- IBSRELA$136
How this compares
$2,718 in reported general payments places this provider in the 90th percentile of 487 nurse practitioner providers in Delaware.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 20 | $26,103 |
| JardianceEmpagliflozin | 19 | $18,691 |
| RybelsusSemaglutide | 17 | $18,415 |
| EliquisApixaban | 11 | $12,012 |
| MyrbetriqMirabegron | 14 | $6,608 |
| Tramadol Hcl | 109 | $1,286 |
| Atorvastatin Calcium | 49 | $940 |
| Zolpidem Tartrate | 89 | $877 |
| Glycopyrrolate | 14 | $638 |
| Omeprazole | 40 | $528 |
| Trazodone Hcl | 12 | $440 |
| Rosuvastatin Calcium | 19 | $368 |
| Alprazolam | 55 | $359 |
| Clonazepam | 31 | $356 |
| Tamsulosin Hcl | 20 | $262 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $113 | $44,51937 claims |
| Boehringer IngelheimJardiance | $62 | $18,69119 claims |
| PfizerEliquis | $112 | $12,01211 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 487 nurse practitioner providers in Delaware.
Other nurse practitioner in Georgetown
- Kevin ForsythGeorgetown$4K
- Logan FordGeorgetown$4K
- Leena SajGeorgetown$4K
- Meghan McCarterSeaford$170K
- Chandni PatelMiddletown$113K
- Craig LaingMilford$51K
- Colleen DitroWilmington$16K
- Sedelle Henderson-BamideleNewark$13K
- Jennifer HubbardWilmington$12K
- Kathleen HudsonMillville$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.